PL3016948T3 - 2-acyloaminotiazole do leczenia nowotworów - Google Patents

2-acyloaminotiazole do leczenia nowotworów

Info

Publication number
PL3016948T3
PL3016948T3 PL14741222T PL14741222T PL3016948T3 PL 3016948 T3 PL3016948 T3 PL 3016948T3 PL 14741222 T PL14741222 T PL 14741222T PL 14741222 T PL14741222 T PL 14741222T PL 3016948 T3 PL3016948 T3 PL 3016948T3
Authority
PL
Poland
Prior art keywords
acylaminothiazoles
cancer
treatment
Prior art date
Application number
PL14741222T
Other languages
English (en)
Inventor
Carlo Gambacorti-Passerini
Luca Mologni
Leonardo Scapozza
William Bisson
Peter Goekjian
Joseph D'ATTOMA
Original Assignee
Univ Degli Studi Di Milano Bicocca
Univ Geneve
Univ Claude Bernard Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Milano Bicocca, Univ Geneve, Univ Claude Bernard Lyon filed Critical Univ Degli Studi Di Milano Bicocca
Publication of PL3016948T3 publication Critical patent/PL3016948T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL14741222T 2013-07-04 2014-07-03 2-acyloaminotiazole do leczenia nowotworów PL3016948T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001124A ITMI20131124A1 (it) 2013-07-04 2013-07-04 2-acilamminotiazoli per il trattamento del cancro
EP14741222.5A EP3016948B8 (en) 2013-07-04 2014-07-03 2-acylaminothiazoles for the treatment of cancer
PCT/EP2014/064197 WO2015001024A1 (en) 2013-07-04 2014-07-03 2-acylaminothiazoles for the treatment of cancer

Publications (1)

Publication Number Publication Date
PL3016948T3 true PL3016948T3 (pl) 2017-10-31

Family

ID=48877393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14741222T PL3016948T3 (pl) 2013-07-04 2014-07-03 2-acyloaminotiazole do leczenia nowotworów

Country Status (7)

Country Link
US (1) US9708279B2 (pl)
EP (1) EP3016948B8 (pl)
CA (1) CA2917114A1 (pl)
ES (1) ES2636245T3 (pl)
IT (1) ITMI20131124A1 (pl)
PL (1) PL3016948T3 (pl)
WO (1) WO2015001024A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116120261B (zh) * 2022-11-30 2024-01-23 浙大宁波理工学院 一种3-[(4-磺胺哌嗪-1-基)甲基]苯甲酸类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2107054A1 (en) * 2008-04-01 2009-10-07 Università Degli Studi Di Milano - Bicocca Antiproliferative compounds and therapeutic uses thereof
HUE025395T2 (en) * 2011-02-02 2016-02-29 Novartis Ag Methods using ALK inhibitors
HK1198133A1 (en) * 2011-08-02 2015-03-13 辉瑞公司 Crizotinib for use in the treatment of cancer

Also Published As

Publication number Publication date
US20160257658A1 (en) 2016-09-08
EP3016948B8 (en) 2017-07-19
EP3016948A1 (en) 2016-05-11
ES2636245T3 (es) 2017-10-05
ITMI20131124A1 (it) 2015-01-05
EP3016948B1 (en) 2017-05-10
WO2015001024A1 (en) 2015-01-08
US9708279B2 (en) 2017-07-18
CA2917114A1 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
LT3033086T (lt) Kombinuota terapija vėžiui gydyti
IL241232A0 (en) Cancer treatment agents
EP2968348A4 (en) COMPOUNDS FOR THE TREATMENT OF CANCER
HUE045615T2 (hu) Rák kezelésére szolgáló eljárások és készítmények
GB201322725D0 (en) Cancer therapy
SG10201801965RA (en) Treatment of cancer with dihydropyrazino-pyrazines
ZA201608559B (en) Combination therapy for cancer
SG10201913730RA (en) Cancer therapy
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
PT3089749T (pt) Preparações combinadas para o tratamento de cancro
SG11201507847UA (en) Cancer therapy
PL3062790T3 (pl) Połączenia farmaceutyczne do leczenia raka
IL242546A0 (en) New compounds for cancer treatment
IL245551A0 (en) Anti-matriptase antibodies for cancer treatment
IL245037B (en) Treatment for pancreatic cancer
EP2961412A4 (en) CANCER THERAPY
GB201403083D0 (en) Treatment of cancer
EP2991650A4 (en) Methods for the treatment of cancer
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
EP3049078A4 (en) Treatment of cancer
EP3016948B8 (en) 2-acylaminothiazoles for the treatment of cancer
EP3007712A4 (en) Treatment of cancer
EP3013332A4 (en) Cancer treatment
AP2015008905A0 (en) Novel compounds for the treatment of cancer
GB201322346D0 (en) Combination treatment of cancer